CClinicalTrials.gg
Enrolling by invitationNCT07250412Updated Nov 26, 2025

The Accuracy Of 3D Color Ultrasonography for Detecting the Degree of Placenta Accreta Spectrum Invasion

An interventional study of Cesarian section in Placenta Accrete Spectrum, sponsored by Sohag University. Enrolling by invitation at 1 site in Egypt. Open to female participants aged 16 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-11-26.

Sponsored by Sohag University · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
16 Years to 45 Years
Sex
Female
01

Study summary

To evaluate the correlation between preoperative ultrasound imaging findings by 3D Color Doppler Ultrasound and the intraoperative severity of Placenta Accreta Spectrum (PAS) disorders, in order to assess the diagnostic accuracy of sonographic markers and their utility in predicting the extent of placental invasion.

02

Conditions studied

  • Placenta Accrete Spectrum
03

In context

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: Pregnant women with clinical or ultrasound suspicion of PAS, including:

  1. Placenta previa or low-lying placenta
  2. History of previous cesarean section(s) or uterine surgery (e.g., myomectomy, D\&C) 2. Gestational age ≥ 28 weeks at the time of ultrasound evaluation 3. Undergoing planned cesarean delivery in the study hospital 4. Availability of preoperative ultrasound imaging performed using a standardized protocol.

    5. Patient can provide informed Written consent and Agree to participate in the study

    -

    Exclusion Criteria: Patients with incomplete or poor-quality ultrasound data 2. Unavailability of intraoperative confirmation of placental invasion 3. Patients with placental abruption or other causes of acute bleeding requiring emergency delivery without imaging 4. Loss to follow-up prior to delivery 5. Declined consent or withdrew participation from the study

    -

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Ultrasonography

    Procedure: Cesarian section

Interventions

  • ProcedureCesarian section

    Cesarian section for detection the degree of placenta Accreta spectrum invasion comparaple to 3D color Doppler

06

What researchers measure

Primary outcomes

  1. Correlation between preoperative ultrasound findings and the confirmed degree of Placenta Accreta Spectrum (PAS) severity (classified as accreta, increta, or percreta). o The classification will be based on intraoperative surgical findings.

    Time frame: Patient preg 28 wks compare finding intraoperative

  2. Correlation between preoperative ultrasound findings and the confirmed degree of Placenta Accreta Spectrum (PAS) severity (classified as accreta, increta, or percreta). o The classification will be based on intraoperative surgical findings.

    Time frame: Pt preg for more than 28wks preg and compare finding intraoperative

07

Study locations

1 site
  • Faculty of medecine Sohag university
    Sohag, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07250412
Lead sponsor
Sohag University
Responsible party
Mohamed Atef Ahmed (The Accuracy Of 3D Color Ultrasonography for Detecting the degree of placenta Accreta spectrum invasion, Sohag University) — Principal investigator
First posted
Nov 26, 2025
Start date
Sep 10, 2025
Primary completion
Sep 10, 2025
Completion
Mar 1, 2026 (estimated)
Last update
Nov 26, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion